我国结核病实验室诊断进展历程

doi:10.3969/j.issn.1000-6621.2014.09.004

摘要/Abstract

摘要： 实验室诊断是结核病诊断、治疗及预防控制过程中所必需的。我国结核病实验室网络逐步建立和完善，是国家结核病防治规划(NTP)的重要组成部分，在结核病防治工作中起着不可缺少的重要作用。实验室的质量保证工作应该得到足够的重视，从而更好发挥其在诊断、治疗方案制定和疗效评估中的作用。

关键词: 结核/诊断, 实验室技术和方法, 临床实验室信息系统

Abstract: Laboratory diagnostics is the one of essential components for effective control and prevention of tuberculosis, the tuberculosis laboratory network was established since 1991 in China, the feasible diagnostics of Mycobacterium tuberculosis promoted tuberculosis diagnosis and treatment greatly, microbiological confirmation and drug susceptibility testing is important in guiding appropriate therapy especially in the context of TB, especially MDR-TB. The external quality assurance program has scaled up to the hospital system, and we should pay highly attention to quality assurance of tuberculosis laboratory, during the long-term struggle between the human being and Mycobacterium tuberculosis.

Key words: Tuberculosis/diagnosis, Laboratory techniques and procedures, Clinical laboratory information systems

宋媛媛，郑惠文，赵雁林. 我国结核病实验室诊断进展历程[J]. 中国防痨杂志, 2014, 36(9): 764-768. doi: 10.3969/j.issn.1000-6621.2014.09.004

SONG Yuan-yuan, ZHENG Hui-wen, ZHAO Yan-lin. The development of TB laboratory diagnostics in China[J]. Chinese Journal of Antituberculosis, 2014, 36(9): 764-768. doi: 10.3969/j.issn.1000-6621.2014.09.004

参考文献

［1］赵雁林, 尚美. 我国结核病实验室诊断的现状. 中华检验医学杂志, 2007, 30(7): 725-728.
［2］European Centre for Disease Prevention and Control. Mas-tering the basic of TB control: development of a handbook on TB diagnostic methods. Stockholm: European Centre for Di-sease Prevention and Control, 2011.
［3］Murray PR. Manual of Clinical Microbiology. 9th ed. Wa-shington: American Society for Microbiology Press, 2007.
［4］Use of Liquid TB Culture and Drug Susceptibility Testing(DST) in Low and Medium Income Settings//World Health Organization. Summary report of the Expert Group Meeting on the use of liquid culture media. Geneva: World Health Organization, 2007.
［5］World Health Organization. Framework for implementing new tuberculosis diagnostics. Geneva: World Health Organization, 2010.
［6］World Health Organization. Laboratory services in tuberculosis control. Part Ⅲ Culture. WHO/TB/98.258.Geneva: World Health Organization, 1998.
［7］World Health Organization. Laboratory services in tuberculosis control. Part Ⅰ organization and management. WHO/TB/98.258. Geneva: World Health Organization, 1998.
［8］Thorpa TC, Wilson ML, Tumer JE, et al. BacT/Alert:an automated colorimetric microbial detection system. J Clin Microbiol,1990, 28(7):1608-1612.
［9］Huang Q, Liu Z, Liao Y, et al. Multiplex fluorescence mel-ting curve analysis for mutation detection with dual-labeled, self-quenched probes. PLoS One, 2011, 6(4): e19206.
［10］胡思玉, 牛建军, 权胜卯, 等. 探针熔解分析法检测结核分枝杆菌异烟肼耐药突变的应用和评价. 中华检验医学杂志, 2011, 34(10): 935-939.
［11］Pang Y, Xia H, Zhang Z, et al. Multicenter evaluation of genechip for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol, 2013, 51(6): 1707-1713.
［12］周杨, 欧喜超, 乐军, 等. 基因芯片诊断耐多药结核病的临床多中心研究. 中华检验医学杂志, 2011, 34(9): 793-799.
［13］Ling DI, Zwerling AA, Pai M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analy-sis. Eur Respir J, 2008, 32(5): 1165-1174.
［14］李强, 欧喜超, 夏辉, 等. Genotype MTBDRplus 快速耐药诊断方法在地市级结核病医院应用的评估研究. 中国预防医学杂志, 2013,14(1): 35-38.
［15］Fang R, Li X, Hu L, et al. Cross-priming amplification for rapid detection of Mycobacterium tuberculosis in sputum specimens. J Clin Microbiol, 2009,47(3): 845-847.
［16］Ou X, Song Y, Zhao B, et al. A multicenter study of cross-priming amplification for tuberculosis diagnosis at peripheral level in China. Tuberculosis (Edinb), 2014,94(4):428-433.
［17］周静宇, 徐生梅. 交叉引物扩增技术快速检测结核分枝杆菌. 临床检验杂志, 2010,28(1): 22.
［18］倪丽丽, 罗柳林, 景玲杰, 等. 恒温扩增实时荧光检测技术在肺结核诊断中的临床价值. 中华检验医学杂志, 2012, 35(8): 702-705.
［19］崔振玲, 沙巍, 黄晓辰, 等. RNA 恒温扩增技术快速检测痰标本中结核分枝杆菌的研究. 中华结核和呼吸杂志, 2012, 34(12): 894-897.
［20］Mori Y, Kanda H, Notomi T. Loop-mediated isothermal amplification (LAMP): recent progress in research and development. J Infect Chemother, 2013, 19(3):404-411.
［21］Ou X, Li Q, Xia H, et al. Diagnostic accuracy of the PURE-LAMP test for pulmonary tuberculosis at the county-level laboratory in China. PLoS One, 2014, 9(5):e94544.
［22］Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med, 2010, 363(11): 1005-1015.
［23］Van Rie A, Page-Shipp L, Scott L, et al. Xpert MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope. Expert Rev Mol Diagn, 2010, 10(7): 937-946.
［24］张治国, 欧喜超, 孙倩, 等. 利福平耐药实时荧光定量核酸扩增技术检测痰标本中结核分枝杆菌及其耐药性的研究. 中国防痨杂志, 2013, 35（1）：13-16.
［25］Del Portillo P, Murillo LA, Patarroyo ME. Amplification of a species-specific DNA fragment of Mycobacterium tuberculosis and its possible use in diagnosis. J Clin Microbiol, 1991,29（10）:2163-2168.
［26］Viana-Niero C, de Haas PE, van Soolingen D, et al. Analysis of genetic polymorphisms affecting the four phospholipase C (plc) genes in Mycobacterium tuberculosis complex clinical isolates. Microbiology, 2004,150(Pt 4):967-978.
［27］Andersen P, Munk ME, Pollock JM,et al. Specific immune-based diagnosis of tuberculosis. Lancet, 2000, 356(9235):1099-1104.
［28］Balcells ME, Pérez CM, Chanqueo L, et al. A comparative study of two different methods for the detection of latent tuberculosis in HIV-positive individuals in Chile. Int J Infect Dis, 2008,12(6):645-652.
［29］Higuchi K, Kawabe Y, Mitarai S, et al. Comparison of performance in two diagnostic methods for tuberculosis infection. Med Microbiol Immunol, 2009, 198(1):33-37.

[1]	戴广明, 王芬, 曹廷明, 褚洪迁, 黄海荣, 孙照刚. 实时荧光定量PCR检测不同结核标本及其联合玻璃珠磨菌法检测价值的初步研究[J]. 中国防痨杂志, 2022, 44(5): 450-454.
[2]	雷静, 邬霞, 谈小文, 李爱芳, 崔晓利, 康磊, 庞健健, 任斐, 吴守振, 杨翰. GeneXpert MTB/RIF Ultra检测手术组织对结核病的诊断价值[J]. 中国防痨杂志, 2022, 44(2): 141-146.
[3]	付亮, 邓国防. 实验室检测技术在肺结核活动性判断中的应用进展[J]. 中国防痨杂志, 2020, 42(6): 626-629.
[4]	李自慧, 张宗德. 结核性脑膜炎实验室诊断现状与展望[J]. 中国防痨杂志, 2020, 42(5): 442-448.
[5]	吕纯阳,罗晶晶,石华,李明远,江咏梅. 儿童结核病的实验室诊断现状与进展[J]. 中国防痨杂志, 2020, 42(2): 178-184.
[6]	梁建琴, 吴雪琼. 《结核病患者外周血淋巴细胞亚群检测及临床应用专家共识》解读[J]. 中国防痨杂志, 2020, 42(12): 1276-1279.
[7]	杨翰, 李爱芳, 王佩, 党丽云. DNA实时荧光恒温扩增法在结核病临床检测中的应用价值[J]. 中国防痨杂志, 2020, 42(12): 1294-1298.
[8]	杨映晖, 伍定辉, 苏伟明, 董春萍, 姚向阳. 基因芯片法在结核分枝杆菌耐药基因快速诊断中的应用价值[J]. 中国防痨杂志, 2020, 42(11): 1191-1195.
[9]	《中国防痨杂志》编辑委员会. 结核病患者外周血淋巴细胞亚群检测及临床应用专家共识[J]. 中国防痨杂志, 2020, 42(10): 1009-1016.
[10]	石倩, 陈志. 风湿性疾病并发肺结核患者的三种免疫学指标检测结果分析[J]. 中国防痨杂志, 2020, 42(10): 1087-1091.
[11]	马晓光, 石洁, 徐行勇, 朱岩昆, 王少华, 郑丹薇, 孙国清, 孙定勇, 苏茹月. 结核分枝杆菌聚合酶螺旋反应检测方法的建立及效果评价[J]. 中国防痨杂志, 2020, 42(10): 1121-1127.
[12]	任航空,段李明,郑琴芳. 两种技术对不同手术标本进行检测诊断胸壁结核的价值[J]. 中国防痨杂志, 2020, 42(1): 74-78.
[13]	孟素华. GeneXpert MTB/RIF检测技术在结核性胸膜炎诊断中的应用价值[J]. 中国防痨杂志, 2019, 41(9): 1005-1008.
[14]	黄毅,杨翰,冯璇,刘媛,张耀辉,张琦. 超声引导下获取标本行病理学与结核相关检测对结核性胸膜炎的诊断价值[J]. 中国防痨杂志, 2019, 41(8): 833-837.
[15]	代小伟,陈双双,杨新宇,赵琰枫,田丽丽,易俊莉,陈昊,丁北川. 四种结核分枝杆菌检测方法临床诊断效能的评价[J]. 中国防痨杂志, 2019, 41(8): 876-881.